Clinical Trials Logo

Filter by:
NCT ID: NCT00808184 Completed - Solid Tumor Clinical Trials

Pharmacokinetic Study of CPT-11, Raltegravir and Midazolam With Characterisation of UGT1A1 Genotype

Start date: April 2010
Phase: Phase 4
Study type: Interventional

The objectives of this study are: To correlate pharmacokinetic parameters of raltegravir and midazolam with irinotecan (CPT-11) and its metabolite SN-38. To correlate the genotype of UGT1A1 of patients receiving CPT-11 chemotherapy with irinotecan and raltegravir pharmacokinetic parameters. To model pharmacokinetic and pharmacodynamic behaviour of CPT-11 in the study population.

NCT ID: NCT00808067 Completed - Atrial Fibrillation Clinical Trials

RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial

Start date: November 2008
Phase: Phase 3
Study type: Interventional

The purposes of this study are: 1. To evaluate the long-term safety of dabigatran etexilate 2. To assess the effect of a knowledge translation intervention on patient outcomes

NCT ID: NCT00806624 Completed - Stroke Clinical Trials

DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation

Start date: October 2007
Phase: Phase 2
Study type: Interventional

This study will be conducted in male and female subjects aged 18 to 80 years, inclusive, with non-valvular AF and a CHADS2 Score of at least 1. Subjects will be treated on an outpatient basis. The subjects will be allocated randomly to the open-label warfarin or any double-blind DU-176b dosages. DU-176b will be administered orally for 12 weeks at two fixed doses. Warfarin will be used as active control. Warfarin dosing will be managed and monitored by the Investigator with the dose adjusted to achieve an INR of 2.0 to 3.0, inclusive. The primary endpoints are incidence of major, clinically relevant non-major and minor bleeding events (all bleeding).

NCT ID: NCT00802490 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder

Effectiveness of a Electroencephalogram (EEG) Biofeedback for the Treatment of ADHD

EEG
Start date: May 2008
Phase: N/A
Study type: Interventional

The aim of this study is to investigate if electroencephalogram (EEG) biofeedback incorporating the use of video games is effective in improving inattentive symptoms in children with ADHD.

NCT ID: NCT00800553 Completed - Sleep Deprivation Clinical Trials

fMRI-behavioral Study of Cholinergic Augmentation With Donepezil in Healthy Sleep Deprived Adults

Start date: November 2006
Phase: Phase 4
Study type: Interventional

The purpose of this study was to characterize how the anti-cholinesterase inhibitor (AChE-I) donepezil modulates brain regions involved in visual short-term memory, episodic memory and inhibitory efficiency following 24 hours of total sleep deprivation using fMRI as an additional marker for drug effect.

NCT ID: NCT00798889 Completed - Solid Tumors Clinical Trials

Rollover Protocol for Prior SU011248 Protocols

Start date: March 2004
Phase: N/A
Study type: Interventional

The objective of this protocol is to provide SU011248 treatment for patients who have participated in a SU011248 protocol and are eligible to enter this protocol

NCT ID: NCT00796926 Completed - Blepharitis Clinical Trials

Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes

Start date: July 2009
Phase: Phase 3
Study type: Interventional

Systane Ultra is at least as efficacious and safe as Refresh Tears in Asian people with Dry Eyes

NCT ID: NCT00795145 Completed - Clinical trials for Bacterial Infections

A Study To Assess The Effect Of Linezolid On QTc Interval

Start date: December 2008
Phase: Phase 1
Study type: Interventional

The FDA has asked Pfizer to assess the risk of linezolid on QT interval (obtained from ECG readings) which could predispose patients to ventricular arrhythmias. This study is conducted to satisfy this requirement.

NCT ID: NCT00794157 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Start date: November 2008
Phase: Phase 3
Study type: Interventional

This study was designed to provide pivotal confirmation of efficacy and safety data for 2 doses of indacaterol (150 and 300 µg once daily [od]) in patients with moderate to severe chronic obstructive pulmonary disease (COPD). Data from this study will be used for the registration of indacaterol in Japan.

NCT ID: NCT00791778 Completed - Ovarian Neoplasms Clinical Trials

Comparison of Nexavar/Placebo as Maintenance Therapy for Patients With Advanced Ovarian or Primary Peritoneal Cancer

Start date: November 2008
Phase: Phase 2
Study type: Interventional

Comparison of Nexavar with a placebo as maintenance therapy for patients with advanced Ovarian or primary Peritoneal cancers in complete remission following surgery and one regimen of chemotherapy.